Common use of Input Clause in Contracts

Input. THERAVANCE shall regularly advise MYLAN of the status of all THERAVANCE Patents in the Territory, and shall provide MYLAN with copies of all material documentation concerning THERAVANCE Patents in the Territory, including all correspondence to and from any Governmental Authority. Prior to filing new THERAVANCE Patents, including patent applications claiming THERAVANCE Inventions, or significant prosecution documents relating to THERAVANCE Patents in the Territory, THERAVANCE shall solicit MYLAN’s advice on the content of the patent application or prosecution document and THERAVANCE shall take into account and incorporate MYLAN’s reasonable comments related thereto, unless (without fault of THERAVANCE) deadlines will not permit such review or MYLAN notifies THERAVANCE that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, THERAVANCE shall have the final decision-making authority with respect to any action relating to Patents claiming THERAVANCE Inventions or THERAVANCE Patents, subject to the provisions of Section 12.02(d) or Section 12.02(h), although THERAVANCE and MYLAN shall seek to agree on which Countries in the Territory in which THERAVANCE Patents shall be filed and the content of patent applications or prosecution documents.

Input. THERAVANCE MYLAN shall regularly advise MYLAN THERAVANCE of the status of all THERAVANCE MYLAN Product Patents in the Territoryand, and at THERAVANCE's request, shall provide MYLAN THERAVANCE with copies of all material documentation concerning THERAVANCE Patents in the TerritoryMYLAN Product Patents, including all correspondence to and from any Governmental Authority. Prior to filing new THERAVANCE Patents, including patent applications claiming THERAVANCE Inventions, or significant prosecution documents relating to THERAVANCE Patents in the TerritoryMYLAN Product Patents, THERAVANCE MYLAN shall solicit MYLAN’s THERAVANCE's advice on the content of the patent application or prosecution document and THERAVANCE MYLAN shall take into account and incorporate MYLAN’s THERAVANCE's reasonable comments related thereto, unless (without fault of THERAVANCEMYLAN) deadlines will not permit such review or THERAVANCE notifies MYLAN notifies THERAVANCE that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, THERAVANCE MYLAN shall have the final decision-making authority with respect to any action relating to MYLAN Product Patents claiming THERAVANCE Inventions or THERAVANCE Patents, subject to the provisions of Section 12.02(d12.02(e) or Section 12.02(h), although THERAVANCE and MYLAN shall seek to agree on which Countries in the Territory in which THERAVANCE MYLAN Product Patents shall be filed within the priority period and the content of patent applications or prosecution documentsdocuments with respect to the MYLAN Product Patents.

Input. THERAVANCE MYLAN shall regularly advise MYLAN THERAVANCE of the status of all THERAVANCE MYLAN Product Patents in the Territoryand, and at THERAVANCE’s request, shall provide MYLAN THERAVANCE with copies of all material documentation concerning THERAVANCE Patents in the TerritoryMYLAN Product Patents, including all correspondence to and from any Governmental Authority. Prior to filing new THERAVANCE Patents, including patent applications claiming THERAVANCE Inventions, or significant prosecution documents relating to THERAVANCE Patents in the TerritoryMYLAN Product Patents, THERAVANCE MYLAN shall solicit MYLANTHERAVANCE’s advice on the content of the patent application or prosecution document and THERAVANCE MYLAN shall take into account and incorporate MYLANTHERAVANCE’s reasonable comments related thereto, unless (without fault of THERAVANCEMYLAN) deadlines will not permit such review or THERAVANCE notifies MYLAN notifies THERAVANCE that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, THERAVANCE MYLAN shall have the final decision-making authority with respect to any action relating to MYLAN Product Patents claiming THERAVANCE Inventions or THERAVANCE Patents, subject to the provisions of Section 12.02(d12.02(e) or Section 12.02(h), although THERAVANCE and MYLAN shall seek to agree on which Countries in the Territory in which THERAVANCE MYLAN Product Patents shall be filed within the priority period and the content of patent applications or prosecution documentsdocuments with respect to the MYLAN Product Patents.

Input. THERAVANCE shall regularly advise MYLAN of the status of all THERAVANCE Patents in the Territory, and shall provide MYLAN with copies of all material documentation concerning THERAVANCE Patents in the Territory, including all correspondence to and from any Governmental Authority. Prior to filing new THERAVANCE Patents, including patent applications claiming THERAVANCE Inventions, or significant prosecution documents relating to THERAVANCE Patents in the Territory, THERAVANCE shall solicit MYLAN’s 's advice on the content of the patent application or prosecution document and THERAVANCE shall take into account and incorporate MYLAN’s 's reasonable comments related thereto, unless (without fault of THERAVANCE) deadlines will not permit such review or MYLAN notifies THERAVANCE that it does not wish to review such documents. In the event of a dispute between the Parties regarding the content of patent applications or prosecution documents, THERAVANCE shall have the final decision-making authority with respect to any action relating to Patents claiming THERAVANCE Inventions or THERAVANCE Patents, subject to the provisions of Section 12.02(d) or Section 12.02(h), although THERAVANCE and MYLAN shall seek to agree on which Countries in the Territory in which THERAVANCE Patents shall be filed and the content of patent applications or prosecution documents.